Vol. 2 No. 1 (2015): January-April 2015

Published: 2015-04-30

Point of View

The Pharmaceutical Sector is at Default Risk. A Proposal to Re-Establish the Economic Balance and Define a New Governance

Nello Martini

53-58
- PDF
DOI: https://doi.org/10.33393/grhta.2015.324

Original Research Articles

Cost-effectiveness of ponatinib in chronic myeloid leukemia in Italy Valutazione di costo-efficacia di ponatinib nella terapia della leucemia mieloide cronica in Italia

Carlo Lucioni, Sergio Iannazzo, Silvio Mazzi, Giorgia Saporiti, Silvia Chiroli

1-16
- PDF
DOI: https://doi.org/10.33393/grhta.2015.320
Cost-effectiveness analysis of paliperidone palmitate versus long-acting risperidone as maintenance treatment in schizophrenia patients in Italy Analisi di costo efficacia di paliperidone palmitato rispetto a risperidone a rilascio prolungato nel trattamento di mantenimento dei pazienti affetti da schizofrenia in Italia

Roberto Ravasio, Giuseppe Nicolò, Marco Vaggi

17-32
- PDF
DOI: https://doi.org/10.33393/grhta.2015.321
Social cost of chronic pain in Italy Il costo sociale del dolore cronico in Italia

Massimo Allegri, Carlo Lucioni, Silvio Mazzi, Giulio Serra

33-42
- PDF
DOI: https://doi.org/10.33393/grhta.2015.322
Budget impact of pneumococcal vaccination in adults and elderly in Italy Budget impact analysis della vaccinazione anti-pneumococcica negli adulti/anziani in italia

Francesco Saverio Mennini, Andrea Marcellusi, Patrizia Giannantoni, Stefano Valente, Alessandro Rinaldi, Elisabetta Franco

43-52
- PDF
DOI: https://doi.org/10.33393/grhta.2015.323

Correspondence

New oncological therapies and the "right" price

Enrico Bosone

59-60
- PDF (Italian)
DOI: https://doi.org/10.33393/grhta.2015.325
Bevacizumab in the treatment of metastatic colorectal cancer: the RFOM in the experience of the A.O. University of Siena

Davide Paoletti, Silvano Giorgi

61-62
- PDF (Italian)
DOI: https://doi.org/10.33393/grhta.2015.326

Congress report

14th National Conference on Pharmaceutical Economics and Policy and Health Technologies Novara, 23 June 2015

64-67
- PDF (Italian)
DOI: https://doi.org/10.33393/grhta.2015.328

Addendum

Addendum to the article "Health Technology Assessment and vaccinations in Italy"

Prof. Roberto Gasparini

63
- PDF (Italian)
DOI: https://doi.org/10.33393/grhta.2015.327